TY - ABST
T1 - Anti-fibrotic effect of rifaximin in early alcohol-related liver disease: a double-blind, randomised, placebo-controlled trial
AU - Israelsen, Mads Egerod
AU - Stæhr Madsen, Bjørn
AU - Torp, Nikolaj Christian
AU - Johansen, Stine
AU - Dalby Hansen, Camilla
AU - Detlefsen, Sönke
AU - Andersen, Peter
AU - Hansen, Johanne Kragh
AU - Lindvig, Katrine Prier
AU - Nytoft Rasmussen, Ditlev
AU - Thorhauge, Katrine Holtz
AU - Kjærgaard, Maria
AU - Arumugam, Mani
AU - Hansen, Torben
AU - Trebicka, Jonel
AU - Thiele, Maja
AU - Krag, Aleksander
PY - 2022/7/1
Y1 - 2022/7/1
U2 - 10.1016/S0168-8278(22)00429-9
DO - 10.1016/S0168-8278(22)00429-9
M3 - Konferenceabstrakt i tidsskrift
SN - 0168-8278
VL - 77
SP - S2
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - Suppl. 1
T2 - The International Liver Congress 2022
Y2 - 22 June 2022 through 26 June 2022
ER -